The forecasted sales of diabetes medicine in Spain display a steady upward trend. In 2023, the actual sales were XYZ billion USD PPP. Sales are projected to increase from 4.32 billion USD PPP in 2024 to 5.7 billion USD PPP by 2028. The year-on-year growth rates for 2025, 2026, 2027, and 2028 are 8.1%, 7.5%, 6.8%, and 6.3% respectively. The Compound Annual Growth Rate (CAGR) for the period from 2024 to 2028 is approximately 7.2%.
Future trends to watch for include advancements in diabetes treatment, a growing aging population, lifestyle changes contributing to higher diabetes prevalence, and the introduction of innovative therapies that could drive higher expenditure and market growth.
